[Glucose tolerance (glucose infusion test), insulin plasma level and free fatty acids before and following 8-week treatment with beta-pyridylcarbinole in patients with hypercholesteremia].
D000328:Adult; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005951:Glucose Tolerance Test; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007328:Insulin / Q000097:blood*; D000432:Methanol / Q000627:therapeutic use*; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011725:Pyridines; D000432:Methanol
Glucosetoleranz (Glucose-Infusionstest), Plasma-Insulinspiegel und freie Fettsäuren vor und nach 8-wöchiger Behandlung mit Beta-Pyridylcarbinol bei Patienten mit Hypercholesterinämie.